Association between sleep insufficiency and dyslipidemia: a cross-sectional study among Greek adults in the primary care setting
- PMID: 35273747
- PMCID: PMC8889970
- DOI: 10.5935/1984-0063.20200124
Association between sleep insufficiency and dyslipidemia: a cross-sectional study among Greek adults in the primary care setting
Abstract
Objective: To investigate the potential association between sleep insufficiency and dyslipidemia (DL) in the primary care setting using self-reported questionnaires.
Material and methods: 957 adults aged between 19 and 86 years old from the rural area of Thrace, Greece were enrolled in this cross-sectional study. Multistage stratifed cluster sampling was used and the subjects were classifed into three groups according to sleep duration [short (<6h), normal (6-8h), and long (>8h) sleep duration]. DL was defined by a positive response to the question "Have you ever been told by a doctor or health professional that your blood cholesterol or triglyceride levels were high?", or if they were currently taking antilipidemic agents. Sleep quality, utilizing Epworth sleepiness scale, Athens insomnia scale, Pittsburgh sleep quality index and Berlin questionnaire, was also examined.
Results: DL prevalence was significantly associated with short sleep duration (aOR=2.18, p<0.001) and insomnia (aOR=1.43, p=0.050), while its relation with poor sleep quality (aOR=1.31, p=0.094) and risk for obstructive sleep apnea (aOR=1.32, p=0.097) were of marginal statistical significance. Concerning insomnia subtypes, DL was significantly associated with difficulties maintaining sleep (aOR=2.99, p<0.001) and early morning awakenings (aOR=1.38, p=0.050), but not difficulties initiating sleep (aOR=1.18, p=0.328).
Conclusion: This study reveals an association between sleep pathology and DL. Thus, early pharmacological and cognitive or behavioral interventions that improve sleep are deemed necessary in order to decrease DL burden.
Keywords: Cross-Sectional Study; Dyslipidemia; Insomnia; Sleep Duration; Sleep Quality.
Conflict of interest statement
CONFLICTS OF INTEREST The authors report no conflicts of interest
References
-
- GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct;388(10053):1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
-
- Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec;106(25):3143–3421. - PubMed
-
- O’Malley PG, Arnold MJ, Kelley C, Spacek L, Buelt A, Natarajan S, et al. Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2020 Nov;173(10):822–829. doi: 10.7326/M20-4648. - DOI - PubMed
LinkOut - more resources
Full Text Sources